Alzheimer’s trust lobbies for extra research cash

The Alzheimer’s Research Trust (ART) is stepping up PR activity ahead of a drive to increase funding and raise its profile.

The Cambridge-based charity wants to raise awareness of its scientific research into causes of the condition and the search for a vaccine.

It has hired Munro & Forster Communications to handle media relations and public affairs.

ART chief executive Rebecca Wood said the charity had hitherto under-invested in PR but had now allocated extra resources to take on the agency in its bid to secure future funding.

'Munro & Forster has been appointed to handle proactive media relations and parliamentary lobbying,' said Wood. 'Its brief is to
promote ART's scientific research, boost the charity's profile and keep supporters updated on the progress of our research programmes.'

Research programmes include studies into vitamins that accelerate or decelerate the disease, blood tests for Alzheimer's and even a possible vaccine.

ART has to turn down 75 per cent of funding applications. It wants to increase public donations through coverage of its media work.

The charity is also preparing to tackle the Government over underfunding. It claims the £11 spent on research per patient is not enough, especially when compared with other conditions such as cancer, which receives around £289 per patient for research.

Latest figures from the charity reveal more than 500,000 people in the UK suffer from Alzheimer's.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in